NovoCure (NASDAQ:NVCR)

CAPS Rating: 3 out of 5

Caps

How do you think NVCR will perform against the market?

Add Stock to CAPS Watchlist

All Players

34 Outperform
3 Underperform
 

All-Star Players

18 Outperform
1 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NVCR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NVCR VS S&P 500 (SPY)

NVCR Summary

Fools bullish on NVCR are also bullish on:

Fools bearish on NVCR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NVCR.

Recs

0
Member Avatar TMFTypeoh (94.26) Submitted: 4/3/2018 2:05:18 PM : Outperform Start Price: $20.05 NVCR Score: +69.30

Great technology with lots of room to run.

Recs

0
Member Avatar meridius91 (85.63) Submitted: 10/23/2017 11:26:34 AM : Outperform Start Price: $18.43 NVCR Score: +84.31

The "rule-maker" in a brand new approach to cancer treatment using magnetic fields. They may only be playing in an niche brain cancer indication currently but there is potential to scale this up to many other types of cancer as well. Combine their moat and market opportunity with their broadly complimentary treatment, this is a winner!

Recs

0
Member Avatar SuzyP99 (63.01) Submitted: 8/22/2017 6:00:37 PM : Outperform Start Price: $18.75 NVCR Score: +75.27

Non-invasive novel approach to cancer treatment. Has received FDA approval recently and is just beginning to familiarize doctors with the device. Recently received reimbursement status in Austria.

Leaderboard

Find the members with the highest scoring picks in NVCR.

Score Leader

oldlumike

oldlumike (23.93) Score: +180.72

The Score Leader is the player with the highest score across all their picks in NVCR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
oldlumike 23.93 5/8/2017 Outperform 5Y $11.95 +197.39% +16.67% +180.72 0 Comment
lumike17 43.78 5/8/2017 Outperform 5Y $11.95 +197.39% +16.69% +180.70 0 Comment
stcksrus 95.76 7/27/2016 Outperform 5Y $11.69 +204.11% +28.62% +175.49 0 Comment
stoledude 61.99 11/13/2017 Outperform 5Y $17.30 +105.49% +8.56% +96.93 0 Comment
synapse 95.95 10/20/2017 Outperform 5Y $18.25 +94.79% +8.82% +85.97 0 Comment
meridius91 85.63 10/23/2017 Outperform 5Y $18.43 +92.94% +8.63% +84.31 1 Comment
lumike176 40.66 7/3/2017 Outperform 5Y $17.87 +98.94% +15.11% +83.83 0 Comment
freecapital 79.19 7/18/2017 Outperform 5Y $18.35 +93.73% +13.88% +79.85 1 Comment
SuzyP99 63.01 8/23/2017 Outperform 1Y $18.75 +89.60% +14.33% +75.27 1 Comment
TMFpessen 90.71 12/5/2017 Outperform 5Y $19.95 +78.24% +5.71% +72.53 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.67 10/7/2015 Outperform 3W $15.94 +123.02% +40.07% +82.95 0 Comment

Featured Broker Partners


Advertisement